These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30544212)

  • 1. Cytokine, Chemokine, and Cytokine Receptor Changes Are Associated With Metabolic Improvements After Bariatric Surgery.
    Wolf RM; Jaffe AE; Steele KE; Schweitzer MA; Magnuson TH; Wolfe A; Wong GW
    J Clin Endocrinol Metab; 2019 Mar; 104(3):947-956. PubMed ID: 30544212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery.
    Wolf RM; Steele KE; Peterson LA; Zeng X; Jaffe AE; Schweitzer MA; Magnuson TH; Wong GW
    J Clin Endocrinol Metab; 2016 May; 101(5):2211-7. PubMed ID: 26982010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy.
    Terra X; Auguet T; Guiu-Jurado E; Berlanga A; Orellana-Gavaldà JM; Hernández M; Sabench F; Porras JA; Llutart J; Martinez S; Aguilar C; Del Castillo D; Richart C
    Obes Surg; 2013 Nov; 23(11):1790-8. PubMed ID: 23832521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.
    Miller GD; Nicklas BJ; Fernandez A
    Surg Obes Relat Dis; 2011; 7(5):618-24. PubMed ID: 21546319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
    Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
    J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
    Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
    Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.
    Herrero-Aguayo V; Sáez-Martínez P; López-Cánovas JL; Prados-Carmona JJ; Alcántara-Laguna MD; López FL; Molina-Puerta MJ; Calañas-Continente A; Membrives A; Castilla J; Ruiz-Ravelo J; Alonso-Echague R; Yubero-Serrano EM; Castaño JP; Gahete MD; Gálvez-Moreno MA; Luque RM; Herrera-Martínez AD
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4917-e4934. PubMed ID: 34363480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric surgery improves clinical outcomes and adiposity biomarkers but not inflammatory cytokines SAA and MCP-1 after a six-month follow-up.
    Bratti LOS; do Carmo ÍAR; Vilela TF; Souza LC; Moraes ACR; Filippin-Monteiro FB
    Scand J Clin Lab Invest; 2021 May; 81(3):230-236. PubMed ID: 33827327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.
    Abbas M; Cumella L; Zhang Y; Choi J; Vemulapalli P; Melvin WS; Camacho D
    Obes Surg; 2015 Dec; 25(12):2251-6. PubMed ID: 26001882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.
    Woelnerhanssen B; Peterli R; Steinert RE; Peters T; Borbély Y; Beglinger C
    Surg Obes Relat Dis; 2011; 7(5):561-8. PubMed ID: 21429816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
    Chen Y; Lu J; Nemati R; Plank LD; Murphy R
    Obes Surg; 2019 Nov; 29(11):3605-3621. PubMed ID: 31273649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery.
    Zhang R; Lin B; Parikh M; Fisher EA; Berger JS; Aleman JO; Heffron SP
    Surg Obes Relat Dis; 2020 Oct; 16(10):1554-1560. PubMed ID: 32636175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin levels could be involved in the improvement of insulin resistance after bariatric surgery.
    Santiago-Fernández C; García-Serrano S; Tome M; Valdes S; Ocaña-Wilhelmi L; Rodríguez-Cañete A; Tinahones FJ; García-Fuentes E; Garrido-Sánchez L
    Endocrinol Diabetes Nutr; 2017; 64(7):355-362. PubMed ID: 28745606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
    Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
    Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.
    Pek SLT; Cheng AKS; Lin MX; Wong MS; Chan EZL; Moh AMC; Sum CF; Lim SC; Tavintharan S
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3029. PubMed ID: 29883055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study.
    Fenske WK; Dubb S; Bueter M; Seyfried F; Patel K; Tam FW; Frankel AH; le Roux CW
    Surg Obes Relat Dis; 2013; 9(4):559-68. PubMed ID: 22608055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery.
    Schmatz R; Bitencourt MR; Patias LD; Beck M; da C Alvarez G; Zanini D; Gutierres JM; Diehl LN; Pereira LB; Leal CA; Duarte MF; Schetinger MR; Morsch VM
    Clin Chim Acta; 2017 Feb; 465():72-79. PubMed ID: 27986549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.